advisorsecurities master

KYNBKyntra Bio, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
17885
Ticker
KYNB
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2014-11-14
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
KYNB

Detail

Enriched 2026-08-14 20:47

Market cap
$28,741,595.2
Shares outstanding (class)
4,048,112
Shares outstanding (weighted)
4,048,112
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
34
Location
SAN FRANCISCO, CA
Description

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data